Teva Announces Launch of Authorized Generic of Detrol

13-01-2014 Business Wire HealthComments (0)

GenericsTeva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the launch of the Authorized Generic of Detrol* LA (tolterodine tartrate extended-release capsules) 2 mg and 4 mg in the U.S. market. Detrol LA had annual sales of approximately $571.5 million in the U.S., according to IMS data as of September 30, 2013. *Detrol is a registered trademark of Pfizer Enterprises Sarl. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmac

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top